NYSE:RADRite Aid Stock Price, Forecast & News

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RAD shares have decreased by 1.1% and is now trading at $13.97. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Rite Aid.

Rite Aid is scheduled to release its next quarterly earnings announcement on Wednesday, June 24th 2020. View our earnings forecast for Rite Aid.

Rite Aid Co. (NYSE:RAD) posted its quarterly earnings results on Thursday, April, 16th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.22. The firm earned $5.73 billion during the quarter, compared to analysts' expectations of $5.61 billion. Rite Aid had a negative net margin of 2.06% and a positive return on equity of 0.87%. Rite Aid's revenue was up 6.5% on a year-over-year basis. View Rite Aid's earnings history.

Rite Aid's stock reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

Rite Aid issued an update on its FY21 earnings guidance on Thursday, April, 16th. The company provided earnings per share (EPS) guidance of ($0.22) - $0.19 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.19. The company issued revenue guidance of $22.5-22.9 billion, compared to the consensus revenue estimate of $22.53 billion.

3 equities research analysts have issued 1 year price targets for Rite Aid's stock. Their forecasts range from $12.00 to $12.00. On average, they expect Rite Aid's share price to reach $12.00 in the next twelve months. This suggests that the stock has a possible downside of 14.1%. View analysts' price targets for Rite Aid.

News articles about RAD stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Rite Aid earned a media sentiment score of 0.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutRite Aid.

Rite Aid saw a increase in short interest in April. As of April 30th, there was short interest totaling 13,940,000 shares, an increase of 5.1% from the April 15th total of 13,260,000 shares. Based on an average daily volume of 5,790,000 shares, the days-to-cover ratio is presently 2.4 days. Currently, 26.2% of the company's stock are sold short. View Rite Aid's Current Options Chain.

Some companies that are related to Rite Aid include Covetrus (CVET), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), General Electric (ge), Lantronix (LTRX) and Micron Technology (MU).

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.97%), Invesco Ltd. (5.20%), State Street Corp (3.34%), Parametric Portfolio Associates LLC (1.75%), Geode Capital Management LLC (1.39%) and Creative Planning (0.92%). View institutional ownership trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Creative Planning, Morgan Stanley, Morgan Stanley, Paloma Partners Management Co, JS Capital Management LLC, Engineers Gate Manager LP, and Russell Investments Group Ltd.. View insider buying and selling activity for Rite Aid.

RAD stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Balyasny Asset Management LLC, Parametric Portfolio Associates LLC, Invesco Ltd., State Street Corp, Thrivent Financial for Lutherans, and Bank of New York Mellon Corp. View insider buying and selling activity for Rite Aid.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RAD stock can currently be purchased for approximately $13.97.

Rite Aid has a market capitalization of $764.20 million and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Rite Aid employs 48,000 workers across the globe.

The official website for Rite Aid is www.riteaid.com.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]